| Last visit was: 19 Nov 2025, 13:08 |
It is currently 19 Nov 2025, 13:08 |
|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 730 GMAT Classic 750 GMAT Classic |
5 | Consulting | India |
14 Mar 2024 03:05 AM
|
|
| Full Time MBA |
Admitted
|
Round 2 | 2024 | Waiver | 9 | Consulting | India |
14 Mar 2024 12:56 AM
|
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 710 GMAT Classic | 3.4 | 5 | Consulting | United States |
13 Mar 2024 11:51 PM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 730 GMAT Classic | 3.8 | 5 | Consulting | India |
13 Mar 2024 11:45 PM
|
| Full Time MBA |
Denied with Interview
|
Round 2 | 2024 | 750 GMAT Classic | 11 | Consulting | China |
13 Mar 2024 09:20 PM
|
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2024 | 730 GMAT Classic | 3.2 | 5 | Consulting | India |
13 Mar 2024 09:13 PM
|
| Full Time MBA |
Admitted
|
Round 2 | 2024 | 328 GRE | 8 | Finance: Venture Capital | United States |
13 Mar 2024 07:50 PM
|
|
| Full Time MBA |
Admitted, ($$)
|
Round 2 | 2024 | 6 | Consulting | United States |
13 Mar 2024 06:13 PM
|
||
| Full Time MBA |
Admitted, ($$)
|
Round 2 | 2024 | 720 GMAT Classic | 3.3 | 3 | Healthcare/Pharmaceuticals | United States |
13 Mar 2024 04:23 PM
|
| Full Time MBA |
Admitted, ($$$)
|
Round 2 | 2024 | 710 GMAT Classic | 3.7 | 8 | Non-Profit and Government | India |
13 Mar 2024 04:15 PM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2024 | 335 GRE | 0 | Finance: Investment Banking | Nigeria |
13 Mar 2024 02:10 PM
|
|
| Full Time MBA |
Denied with Interview
|
Round 2 | 2024 | 0 | Consulting | India |
13 Mar 2024 02:09 PM
|
||
| Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2024 | 320 GRE | 3.4 | 4 | Finance: Investment Banking | United States |
13 Mar 2024 02:08 PM
|
| Full Time MBA |
Admitted
|
Round 2 | 2024 | 163 EA | 3.5 | 6 | Insurance | Thailand |
13 Mar 2024 06:18 AM
|
| Full Time MBA |
Denied with Interview
|
Round 1 | 2024 | 325 GRE | 3.9 | 0 | Healthcare/Pharmaceuticals | India |
12 Mar 2024 06:43 PM
|
| Full Time MBA |
Admitted, ($$$$)
|
Round 2 | 2024 | 314 GRE | 3.2 | 3 | Finance: Private Equity | Dominican Republic |
12 Mar 2024 06:33 PM
|
| Full Time MBA |
Admitted
|
Round 2 | 2024 | 750 GMAT Classic | 3.5 | 4 | Finance: Investment Banking | United States |
12 Mar 2024 04:00 PM
|
| Full Time MBA |
Admitted, ($$$$)
|
Round 2 | 2024 | Waiver | 3.7 | 8 | Technology | United States |
12 Mar 2024 03:56 PM
|
| Full Time MBA |
Admitted
|
Round 2 | 2024 | 3.8 | 6 | Energy | India |
12 Mar 2024 01:32 PM
|
|
| Full Time MBA |
Admitted
|
Round 1 | 2024 | 327 GRE | 3.6 | 4 | Consulting | United States |
11 Mar 2024 10:43 AM
|